Bioptimus raised €40M in a funding round in Jan 2025. The company is based in Paris, France. Investors in the round: Andera Partners, Boom Capital Ventures, Bpifrance and 7 others. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
